Bailard’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.1K | Buy |
+11,700
| New | +$99.1K | ﹤0.01% | 739 |
|
|
2025
Q1 | – | Sell |
-14,300
| Closed | -$128K | – | 743 |
|
|
2024
Q4 | $128K | Buy |
+14,300
| New | +$128K | ﹤0.01% | 711 |
|
|
2022
Q3 | – | Sell |
-63,800
| Closed | -$641K | – | 670 |
|
|
2022
Q2 | $641K | Sell |
63,800
-26,200
| -29% | -$263K | 0.03% | 320 |
|
|
2022
Q1 | $1.11M | Hold |
90,000
| – | – | 0.04% | 252 |
|
|
2021
Q4 | $2.06M | Sell |
90,000
-219,000
| -71% | -$5.01M | 0.07% | 202 |
|
|
2021
Q3 | $6.84M | Sell |
309,000
-61,000
| -16% | -$1.35M | 0.23% | 100 |
|
|
2021
Q2 | $4.8M | Buy |
370,000
+56,000
| +18% | +$726K | 0.17% | 123 |
|
|
2021
Q1 | $4.08M | Buy |
314,000
+103,000
| +49% | +$1.34M | 0.15% | 134 |
|
|
2020
Q4 | $2.92M | Hold |
211,000
| – | – | 0.13% | 130 |
|
|
2020
Q3 | $3.11M | Buy |
211,000
+161,000
| +322% | +$2.37M | 0.16% | 113 |
|
|
2020
Q2 | $813K | Buy |
+50,000
| New | +$813K | 0.05% | 216 |
|